REGENXBIO Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $161.7M | $24.8M |
| FY2017 | — | $183.0M | $46.7M |
| FY2018 | — | $508.8M | $75.6M |
| FY2019 | — | $450.2M | $69.5M |
| FY2020 | — | $377.8M | $338.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $161.7M | $24.8M |
| FY2017 | — | $183.0M | $46.7M |
| FY2018 | — | $508.8M | $75.6M |
| FY2019 | — | $450.2M | $69.5M |
| FY2020 | — | $377.8M | $338.4M |